Eurofins Scientific SE Stock
Stocks
ERF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Euronext Paris
11:55:00 2026-08-21 am EDT
|
5-day change | 1st Jan Change | ||
| 72.84 EUR | +0.03% |
|
+3.41% | +16.73% |
| Jul. 23 | Eurofins Scientific SE, H1 2026 Earnings Call, Jul 23, 2026 | |
| Jul. 23 | Eurofins Scientific: BioPharma's slowdown raises questions on 2026 organic growth target |  |
| Market Cap | 12.64B 14.76B 11.83B 10.83B 20.33B 1,412B 20.59B 140B 54.51B 710B 55.43B 54.22B 2,347B | P/E 2026 * |
24.3x | P/E 2027 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 15.99B 18.67B 14.97B 13.7B 25.71B 1,786B 26.05B 177B 68.95B 897B 70.11B 68.58B 2,968B | EV / Sales 2026 * |
2.11x | EV / Sales 2027 * | 1.96x |
| Free-Float |
60.39% | Yield 2026 * |
1.11% | Yield 2027 * | 1.26% |
Last Transcript: Eurofins Scientific SE
| 1 day | +0.03% | ||
| 1 week | +3.41% | ||
| Current month | +6.87% | ||
| 1 month | +4.57% | ||
| 3 months | +16.36% | ||
| 6 months | +7.85% | ||
| Current year | +16.73% |
| 1 week | 68.62 |  | 73 |
| 1 month | 64.56 | | 73 |
| Current year | 56.84 | | 74.32 |
| 1 year | 54.86 | | 74.32 |
| 3 years | 39.47 | | 74.32 |
| 5 years | 39.47 | | 127.68 |
| 10 years | 29.82 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 1986-12-31 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 2014-12-31 |
Christian Wurst
PRN | Corporate Officer/Principal | 54 | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 1986-12-31 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 2014-12-31 |
Valérie Hanote
BRD | Director/Board Member | 60 | 1989-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/27/26 | Buy | Chief Executive Officer | 1,000 | 0.0005% | ||
| 2/27/26 | Buy | Chief Executive Officer | 1,000 | 0.0005% | ||
| 2/27/26 | Buy | Chief Executive Officer | 1,000 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | +3.41% | +7.12% | +35.49% | 14.76B | |
| +1.09% | +5.26% | +4.44% | +26.03% | 51.61B | |
| -1.07% | +2.82% | +474.18% | +601.24% | 44.89B | |
| +1.47% | +9.79% | +40.15% | +21.21% | 42.77B | |
| +1.44% | +7.77% | +19.27% | +90.94% | 42.58B | |
| -0.93% | -4.33% | +17.87% | +51.96% | 31.82B | |
| +1.32% | +7.30% | +36.93% | +152.36% | 17.33B | |
| -0.60% | +1.93% | - | - | 16.63B | |
| +1.28% | +5.41% | +91.01% | +46.93% | 14.09B | |
| -1.17% | +5.57% | -1.97% | -30.78% | 13.29B | |
| Average | +0.29% | +4.55% | +76.55% | +110.60% | 28.98B | |
| Weighted average by Cap. | +0.41% | +4.76% | +97.48% | +139.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.59B 8.86B 7.1B 6.5B 12.2B 848B 12.36B 83.88B 32.71B 426B 33.26B 32.54B 1,408B | 8.01B 9.35B 7.49B 6.86B 12.87B 895B 13.04B 88.54B 34.53B 449B 35.11B 34.35B 1,486B |
| Net income | 531M 620M 497M 455M 853M 59.3B 865M 5.87B 2.29B 29.79B 2.33B 2.28B 98.53B | 660M 770M 617M 565M 1.06B 73.69B 1.07B 7.29B 2.84B 37.02B 2.89B 2.83B 122B |
| Net Debt | 3.35B 3.91B 3.13B 2.87B 5.38B 374B 5.45B 37.02B 14.44B 188B 14.68B 14.36B 622B | 3.01B 3.52B 2.82B 2.58B 4.84B 337B 4.91B 33.31B 12.99B 169B 13.21B 12.92B 559B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | €72.84 | +0.03% | 210,856 |
| 26-08-20 | €72.82 | +3.06% | 323,338 |
| 26-08-19 | €70.66 | +1.44% | 210,639 |
| 26-08-18 | €69.66 | -0.49% | 177,190 |
| 26-08-17 | €70.00 | -0.62% | 201,822 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions
